Issues encountered in recent attempts to develop novel antidepressant agents

Publisher： John Wiley & Sons Inc

E-ISSN： 1749-6632|1345|1|67-73

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1345, Iss.1, 2015-05, pp. : 67-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation

By Jha Manish K.   Trivedi Madhukar H.  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 233-233

MDPI

Access to resources Recommend Favorite

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease

By Corbett Anne   Williams Gareth   Ballard Clive  

Pharmaceuticals, Vol. 6, Iss. 10, 2013-10 ,pp. : 1304-1321

MDPI

Access to resources Recommend Favorite

Protein-Based Blood Substitutes: Recent Attempts at Controlling Pro-Oxidant Reactivity with and Beyond Hemoglobin

By Scurtu Violeta-Florina   Moţ Augustin C.   Silaghi-Dumitrescu Radu  

Pharmaceuticals, Vol. 6, Iss. 7, 2013-07 ,pp. : 867-880

MDPI

Access to resources Recommend Favorite

Transition Metal Intercalators as Anticancer Agents—Recent Advances

By Deo Krishant M.   Pages Benjamin J.   Ang Dale L.   Gordon Christopher P.   Aldrich-Wright Janice R.  

International Journal of Molecular Sciences, Vol. 17, Iss. 11, 2016-10 ,pp. : 1818-1818

MDPI

Access to resources Recommend Favorite

Some Antidepressant Agents (Li+, Monoamine Oxidase Type A Inhibitors) Perturb the Ultradian Clock in Saccharomyces cerevisiae

By Salgado E.   Murray D.B.   Lloyd D.  

Biological Rhythm Research, Vol. 33, Iss. 3, 2002-07 ,pp. : 351-361

Taylor & Francis Ltd

Access to resources Recommend Favorite